Powered by

TissueGen Featured in Nature.com Webcast on Innovations in Drug Delivery Technology

Mar 22, 2017 - Marketwired

TissueGen(R) Inc., developer of ELUTE(R) fiber, a groundbreaking biodegradable fiber format for advanced drug delivery, nerve regeneration, and tissue engineering, today announced that its founder and CSO, Dr. Kevin Nelson, will participate in a BioPharma Dealmakers webcast featuring five companies' innovative drug delivery technologies. The webcast, part of the BioPharma Dealmakers series, is scheduled for 11:00 am EDT on March 29th. Register here.

This webcast will highlight how innova...